Ludovic Gillet

Ludovic Gillet

Auto-generated profile, based on publicly available information

Ludovic Gillet

Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
LGLudovic C. Gillet
Ludovic C. Gillet
PNPedro Navarro
Pedro Navarro
STStephen Tate
Stephen Tate
HRHannes Röst
Hannes Röst
NSNathalie Selevsek
Nathalie Selevsek
RARuedi Aebersold
Ruedi Aebersold
Most proteomic studies use liquid chromatography coupled to tandem mass spectrometry to identify and quantify the peptides generated by the proteolysis of a biological sample. However, with the current methods it remains challenging to rapidly, consistently, reproducibly, accurately, and sensitively detect and quantify large fractions of proteomes across multiple samples. Here we present a new strategy that systematically queries sample sets for the presence and quantity of essentially any protein of interest. It consists of using the information available in fragment ion spectral libraries to mine the complete fragment ion maps generated using a data-independent acquisition method. For this study, the data were acquired on a fast, high resolution quadrupole-quadrupole time-of-flight (TOF) instrument by repeatedly cycling through 32 consecutive 25-Da precursor isolation windows (swaths). This SWATH MS acquisition setup generates, in a single sample injection, time-resolved fragment ion spectra for all the analytes detectable within the 400–1200 m/z precursor range and the user-defined retention time window. We show that suitable combinations of fragment ions extracted from these data sets are sufficiently specific to confidently identify query peptides over a dynamic range of 4 orders of magnitude, even if the precursors of the queried peptides are not detectable in the survey scans. We also show that queried peptides are quantified with a consistency and accuracy comparable with that of selected reaction monitoring, the gold standard proteomic quantification method. Moreover, targeted data extraction enables ad libitum quantification refinement and dynamic extension of protein probing by iterative re-mining of the once-and-forever acquired data sets. This combination of unbiased, broad range precursor ion fragmentation and targeted data extraction alleviates most constraints of present proteomic methods and should be equally applicable to the comprehensive analysis of other classes of analytes, beyond proteomics.

10 March 2014 in Nature Biotechnology
Verified
Journal Article
Closed access
HRHannes L Röst
Hannes L Röst
GRGeorge Rosenberger
George Rosenberger
PNPedro Navarro
Pedro Navarro
LGLudovic Gillet
Ludovic Gillet
SMSaša M Miladinović
Saša M Miladinović
RARuedi Aebersold
Ruedi Aebersold

27 December 2005 in Chemical Reviews
Verified
Journal Article
Closed access
LGLudovic C. J. Gillet
Ludovic C. J. Gillet
OSOrlando D. Schärer
Orlando D. Schärer

2 March 2015 in Nature Medicine
Verified
Journal Article
Open access
PDF file
TGTiannan Guo
Tiannan Guo
PKPetri Kouvonen
Petri Kouvonen
CKChing Chiek Koh
Ching Chiek Koh
LGLudovic C Gillet
Ludovic C Gillet
WWWitold E Wolski
Witold E Wolski
RARuedi Aebersold
Ruedi Aebersold
A method for converting biopsy-size tissue samples into digital files containing the mass spectrometry–measurable proteome of the sample will allow analysis and re-analysis of limited tissue samples. Clinical specimens are each inherently unique, limited and nonrenewable. Small samples such as tissue biopsies are often completely consumed after a limited number of analyses. Here we present a method that enables fast and reproducible conversion of a small amount of tissue (approximating the quantity obtained by a biopsy) into a single, permanent digital file representing the mass spectrometry (MS)-measurable proteome of the sample. The method combines pressure cycling technology (PCT) and sequential window acquisition of all theoretical fragment ion spectra (SWATH)-MS. The resulting proteome maps can be analyzed, re-analyzed, compared and mined in silico to detect and quantify specific proteins across multiple samples. We used this method to process and convert 18 biopsy samples from nine patients with renal cell carcinoma into SWATH-MS fragment ion maps. From these proteome maps we detected and quantified more than 2,000 proteins with a high degree of reproducibility across all samples. The measured proteins clearly distinguished tumorous kidney tissues from healthy tissues and differentiated distinct histomorphological kidney cancer subtypes.

12 February 2015 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
OSOlga T Schubert
Olga T Schubert
LGLudovic C Gillet
Ludovic C Gillet
BCBen C. Collins
Ben C. Collins
PNPedro Navarro
Pedro Navarro
GRGeorge Rosenberger
George Rosenberger
RARuedi Aebersold
Ruedi Aebersold

1 February 2015 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
YLYansheng Liu
Yansheng Liu
ABAlfonso Buil
Alfonso Buil
BCBen C. Collins
Ben C. Collins
LGLudovic Cj Gillet
Ludovic Cj Gillet
LBLorenz C Blum
Lorenz C Blum
RARuedi Aebersold
Ruedi Aebersold
The degree and the origins of quantitative variability of most human plasma proteins are largely unknown. Because the twin study design provides a natural opportunity to estimate the relative contribution of heritability and environment to different traits in human population, we applied here the highly accurate and reproducible SWATH mass spectrometry technique to quantify 1,904 peptides defining 342 unique plasma proteins in 232 plasma samples collected longitudinally from pairs of monozygotic and dizygotic twins at intervals of 2–7 years, and proportioned the observed total quantitative variability to its root causes, genes, and environmental and longitudinal factors. The data indicate that different proteins show vastly different patterns of abundance variability among humans and that genetic control and longitudinal variation affect protein levels and biological processes to different degrees. The data further strongly suggest that the plasma concentrations of clinical biomarkers need to be calibrated against genetic and temporal factors. Moreover, we identified 13 cis‐ SNPs significantly influencing the level of specific plasma proteins. These results therefore have immediate implications for the effective design of blood‐based biomarker studies.